We are live on ! Find out more
COCH icon

Envoy Medical

57 hedge funds and large institutions have $212M invested in Envoy Medical in 2021 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51.39% more ownership

Funds ownership: 0%51.39% (+51%)

Holders
57
Holders Change
+57
Holders Change %
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
57
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EC
51
EJF Capital
Virginia
$292K +$292K +30,000 New
PI
52
PEAK6 Investments
Illinois
$243K +$243K +24,993 New
PCM
53
Prelude Capital Management
New York
$152K +$152K +15,629 New
SGAM
54
Seaport Global Asset Management
New York
$58K +$58.3K +6,000 New
UBS Group
55
UBS Group
Switzerland
$14K +$13.6K +1,401 New
Osaic Holdings
56
Osaic Holdings
Arizona
$5K +$4.86K +500 New
Morgan Stanley
57
Morgan Stanley
New York
$1K +$690 +71 New

COCH Hedge Fund Activity: Q2 2021 in Review

57 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2021, worth a combined $212M.

Buyers outnumbered sellers: 57 funds opened new COCH positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Nomura Holdings, opening a new position worth an estimated $18.6M.

  • 57 institutional investors held Envoy Medical (COCH) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $212M of Envoy Medical stock for Q2 2021.
  • 57 funds opened new Envoy Medical positions in Q2 2021 and 0 closed out, a net change of +57 holders.
  • The largest Envoy Medical buyer in Q2 2021 was Nomura Holdings, an estimated $18.6M added.

Based on aggregated 13F filings for Q2 2021.